Related Experiment Video
Updated: Jul 17, 2026
10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Galectins - potential targets for cancer therapy
Syed Saif Hasan1, Ghulam Md Ashraf, Naheed Banu
1Molecular Biology Unit, National Centre for Cell Science, University of Pune Campus, Ganeshkhind, Pune 411007, Maharashtra, India.
Cancer Letters
|January 9, 2007
Summary
Galectins, a family of proteins, play key roles in cell metabolism and cancer. This review covers their detection, therapeutic potential in cancer, and interactions with other molecules.
Area of Science:
- Molecular Biology
- Cancer Research
- Glycobiology
Background:
- Galectins are a class of carbohydrate-binding proteins known for their diverse regulatory functions in cellular metabolism.
- Aberrant galectin expression is frequently observed in various types of cancer, suggesting their involvement in tumorigenesis.
- Galectins share functional similarities with known apoptosis modulators, highlighting their potential role in cell death pathways.
Purpose of the Study:
- To review recent advancements in methodologies for detecting and identifying galectins.
- To explore the therapeutic applications of galectins in cancer treatment.
- To discuss the interactions between galectins and other glycoconjugates.
- To provide insights into the future diagnostic and therapeutic potential of galectins in oncology.
Main Methods:
- Review of current literature on galectin detection and identification techniques.
- Analysis of studies investigating galectin roles in cancer biology and therapy.
- Exploration of research on galectin-glycoconjugate interactions.
Main Results:
- Significant progress has been made in developing sensitive methods for galectin detection and characterization.
- Galectins demonstrate multifaceted roles in cancer, including proliferation, invasion, and immune evasion.
- Emerging evidence supports galectins as potential therapeutic targets and diagnostic biomarkers in various cancers.
Conclusions:
- Galectins are promising targets for novel cancer therapies due to their involvement in critical cellular processes.
- Further research into galectin interactions and functions will enhance their utility in cancer diagnosis and treatment.
- The development of specific galectin-targeting agents holds significant therapeutic promise for cancer patients.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:25Selectins
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:15Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.